APA (7th ed.) Citation

JSJ, L., SGW, O., ALA, W., MXW, L., GHJ, C., JL, L., . . . SC, L. (2023). Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines. European journal of cancer (Oxford, England : 1990), 193, 113311. https://doi.org/10.1016/j.ejca.2023.113311

Chicago Style (17th ed.) Citation

JSJ, Lim, et al. "Phase II Study of Trifluridine/tipiracil in Metastatic Breast Cancers with or Without Prior Exposure to Fluoropyrimidines." European Journal of Cancer (Oxford, England : 1990) 193 (2023): 113311. https://doi.org/10.1016/j.ejca.2023.113311.

MLA (9th ed.) Citation

JSJ, Lim, et al. "Phase II Study of Trifluridine/tipiracil in Metastatic Breast Cancers with or Without Prior Exposure to Fluoropyrimidines." European Journal of Cancer (Oxford, England : 1990), vol. 193, 2023, p. 113311, https://doi.org/10.1016/j.ejca.2023.113311.